|
End-of-day quote
Euronext Paris
|
||
| - | - |
|
| 09-01 | Global pharma companies that have publicly announced Trump drug pricing agreements | RE |
| 09-01 | GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial | DJ |
| Market Cap | 163B 0 140B 132B 121B 225B 15,452B 227B 1,567B 608B 7,861B 611B 598B 25,849B | P/E 2026 * |
17.9x | P/E 2027 * | 14x |
|---|---|---|---|---|---|
| Enterprise Value | 210B 0 181B 171B 156B 291B 19,961B 293B 2,024B 785B 10,155B 789B 772B 33,392B | EV / Sales 2026 * |
3.38x | EV / Sales 2027 * | 3.44x |
| Free-Float |
59.05% | Yield 2026 * |
6.03% | Yield 2027 * | 6.08% |
Last Transcript : PFIZER
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
Cecile Guegan
DFI | Director of Finance/CFO | 55 | 2026-08-15 |
Rady Johnson
CMP | Compliance Officer | 65 | 2013-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.01% | -5.96% | +58.36% | +108.23% | 1,034B | |
| +1.48% | +0.76% | +55.34% | +71.49% | 654B | |
| +0.67% | -1.53% | +24.39% | +76.60% | 459B | |
| +0.49% | -6.58% | +34.20% | +34.59% | 343B | |
| +0.27% | +2.32% | +29.33% | +46.97% | 307B | |
| +0.12% | -4.01% | +1.06% | +11.93% | 251B | |
| +1.08% | +0.14% | +53.92% | +72.51% | 237B | |
| +2.64% | -2.00% | -17.38% | -53.64% | 202B | |
| -0.21% | +0.56% | +32.43% | +95.19% | 186B | |
| Average | +0.46% | -2.88% | +30.18% | +51.54% | 407.95B | |
| Weighted average by Cap. | +0.26% | -3.31% | +39.22% | +67.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 62.24B 0 53.72B 50.6B 46.17B 86.17B 5,910B 86.86B 599B 232B 3,007B 234B 229B 9,887B | 59.84B 0 51.65B 48.65B 44.39B 82.85B 5,682B 83.51B 576B 223B 2,891B 225B 220B 9,505B |
| Net income | 8.9B 0 7.68B 7.24B 6.6B 12.32B 845B 12.42B 85.7B 33.23B 430B 33.42B 32.69B 1,414B | 11.08B 0 9.56B 9.01B 8.22B 15.34B 1,052B 15.46B 107B 41.37B 535B 41.61B 40.7B 1,760B |
| Net Debt | 47.48B 0 40.99B 38.61B 35.22B 65.74B 4,509B 66.27B 457B 177B 2,294B 178B 174B 7,543B | 42.88B 0 37.02B 34.86B 31.81B 59.37B 4,072B 59.85B 413B 160B 2,072B 161B 158B 6,812B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PFE Stock
- PFZ Stock
Select your edition
All financial news and data tailored to specific country editions
